Potential applications and human biosafety of nanomaterials used in nanomedicine
Open accessThe DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Abstract
With the rapid development of nanotechnology, potential applications of nanomaterials in medicine have been widely researched in recent years. Nanomaterials themselves can be used as image agents or therapeutic drugs, and for drug and gene delivery, biological devices, nanoelectronic biosensors or molecular nanotechnology. As the composition, morphology, chemical properties, implant sites as well as potential applications become more and more complex, human biosafety of nanomaterials for clinical use has become a major concern. If nanoparticles accumulate in the human body or interact with the body molecules or chemical components, health risks may also occur. Accordingly, the unique chemical and physical properties, potential applications in medical fields, as well as human biosafety in clinical trials are reviewed in this study. Finally, this article tries to give some suggestions for future work in nanomedicine research. Copyright © 2017 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
A Magnetic Nanoprobe Technology for Detecting Molecular Interactions in Live Cells
Won, J., Kim, M., Yi, Y.-W., Kim, Y. H., Jung, N., & Kim, T. K. (2005) · Science · doi:10.1126/science.1112869 · Cited by 149 · cited 1×
“Won et al. (2005) reported a technology named magnetism-based interaction capture, which can be used to identify molecular targets based on induced movement of superparamagnetic NPs inside living cells.”
RetractedLiu, W., Su, P., Gonzales, A. A., Wang, N., Zhang, Z., Li, H., Webster, T. J., Wang, J., & Chen, S. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s74418 · Cited by 51 · cited 2×
“Liu et al. (2015b) developed an NIR fluorescence nanoprobe by coating CuInS2/ZnS quantum dots with an amphiphilic bioconjugate and investigated the feasibility of the constructed NIR fluorescence probe in vivo imaging.”
RetractedSilver nanoparticles as a new generation of antimicrobials
Rai, M., Yadav, A., & Gade, A. (2009) · Biotechnology Advances · doi:10.1016/j.biotechadv.2008.09.002 · Cited by 6,173 · cited 1×
“Antibacterial efficiency of nanosize Ag particles are usually associated with the total surface area of the NPs, and are much higher than traditional fine Ag particles (Rai et al., 2009).”
Cancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558 · cited 1×
“Nanowires and nanocantilever arrays are used for the early detection of precancerous and malignant lesions from biological fluids (Ferrari, 2005).”
Nanomaterials and nanoparticles: Sources and toxicity
Buzea, C., Pacheco, I. I., & Robbie, K. (2007) · Biointerphases · doi:10.1116/1.2815690 · Cited by 3,789 · cited 1×
“It leads to NPs being more chemically reactive meaning that a given mass of material in nanoparticulate form will be much more reactive than the same mass of material made up of larger particles (Buzea et al., 2007).”
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags
Qian, X., Peng, X.-H., Ansari, D. O., Yin-Goen, Q., Chen, G. Z., Shin, D. M., Yang, L., Young, A. N., Wang, M. D., & Nie, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1377 · Cited by 2,201 · cited 1×
“Qian et al. (2008) reported that biocompatible and non-toxic NPs such as pegylated gold NPs and surface-enhanced Raman scattering are effective for in vivo tumor targeting and detection.”
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
The emerging nanomedicine landscape
Wagner, V., Dullaart, A., Bock, A.-K., & Zweck, A. (2006) · Nature Biotechnology · doi:10.1038/nbt1006-1211 · Cited by 1,630 · cited 2×
“After extensive reviewing on clinical trial articles of nanomedicine in public journals, we found that most of them focused mainly on reporting the findings of the therapeutic effectiveness of the drugs (Wagner et al., 2006), but not on evaluating the human biosafety of the nanomaterials.”
Nanoparticle Delivery of Cancer Drugs
Wang, A. Z., Langer, R., & Farokhzad, O. C. (2012) · Annual Review of Medicine · doi:10.1146/annurev-med-040210-162544 · Cited by 1,561
Titanium dioxide nanoparticles: a review of current toxicological data
Shi, H., Magaye, R., Castranova, V., & Zhao, J. (2013) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-10-15 · Cited by 1,498 · cited 1×
“In principle, nanomaterial is material of which a single unit is sized (in at least one dimension) between 1 and 100nm (Shi et al., 2013) and it often owns unique physical and chemical properties.”
Self-citationMaier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., & Jordan, A. (2011) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0389-0 · Cited by 1,429 · cited 1×
“They concluded that thermotherapy using magnetic NPs in conjunction with a reduced radiation dose is safe and effective (Maier-Hauff et al., 2011).”
Pharmacology of oleanolic acid and ursolic acid
Liu, J. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(95)90032-2 · Cited by 1,429 · cited 8×
“The size (nm) of the UANLs was not clearly stated in this paper.”
InfluentialWang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381 · cited 1×
“Several approved applications utilizing iron oxide NPs for in vivo magnetic resonance imaging (MRI) enhancement were identified, some are under clinical investigation (Etheridge et al., 2013; Wang et al., 2001).”
Self-citationApplication of Nanoparticles in Electrochemical Sensors and Biosensors
Luo, X., Morrin, A., Killard, A. J., & Smyth, M. R. (2006) · Electroanalysis · doi:10.1002/elan.200503415 · Cited by 1,318 · cited 2×
“Normally, the NPs are chemically more active than those of the corresponding bulk material are (Luo et al., 2006).”
Highly Conductive and Stretchable Silver Nanowire Conductors
Xu, F., & Zhu, Y. (2012) · Advanced Materials · doi:10.1002/adma.201201886 · Cited by 1,314 · cited 1×
“Nanosensors include nanobiological and chemical sensors, nanometer gas sensitive sensors and other types of nanometer sensors (flow, pressure and temperature, etc.) (Feng and Yong, 2012).”
Magnetic Nanoparticles: Surface Effects and Properties Related to Biomedicine Applications
Issa, B., Obaidat, I., Albiss, B., & Haik, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121266 · Cited by 1,245 · cited 2×
“The surface-to-volume ratio (and consequently the fraction of the surface atoms with respect to the bulk ones) also increases (Issa et al., 2013).”
Nanoshell-Enabled Photonics-Based Imaging and Therapy of Cancer
Loo, C., Lin, A., Hirsch, L., Lee, M.-H., Barton, J., Halas, N., West, J., & Drezek, R. (2004) · Technology in Cancer Research & Treatment · doi:10.1177/153303460400300104 · Cited by 1,160 · cited 2×
“Nanoshells possess highly favorable optical and chemical properties for biomedical imaging and therapeutic applications (Loo et al., 2004).”
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Etheridge, M. L., Campbell, S. A., Erdman, A. G., Haynes, C. L., Wolf, S. M., & McCullough, J. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2012.05.013 · Cited by 1,088
Gold nanoparticles as novel agents for cancer therapy
Jain, S., Hirst, D. G., & O'Sullivan, J. M. (2012) · The British Journal of Radiology · doi:10.1259/bjr/59448833 · Cited by 1,059 · cited 2×
“…radiosensitizers in preclinical models include gold (Botchway et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et…”
Antimicrobial applications of nanotechnology: methods and literature
Webster, T. J., & Seil, I. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24805 · Cited by 1,010
Nanocrystal technology, drug delivery and clinical applications
Müller, R., & Junghanns (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s595 · Cited by 953
Nanosuspensions: a promising drug delivery strategy
Patravale, V. B., Date, A. A., & Kulkarni, R. M. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023691 · Cited by 904 · cited 2×
“(5) Nanometer drug carriers can pass through the biological barriers of the human body, such as the blood–brain barrier, blood–eye barrier, as well as other cell biological membrane barriers, allowing drugs to reach the lesions, and increasing efficacy (Lim and Helpern, 2002; Patravale et al., 2004; Stowe et al., 2012…”
Gold nanoparticles for applications in cancer radiotherapy: Mechanisms and recent advancements
Her, S., Jaffray, D. A., & Allen, C. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.012 · Cited by 865 · cited 2×
“…investigated nanoparticulate radiosensitizers in preclinical models include gold (Botchway et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron…”
A review on nano-TiO2 sol–gel type syntheses and its applications
Macwan, D. P., Dave, P. N., & Chaturvedi, S. (2011) · Journal of Materials Science · doi:10.1007/s10853-011-5378-y · Cited by 788 · cited 1×
“Unique properties make nanomaterials display new features as well as distinct and excellent performance (Macwan et al., 2011).”
Hesketh, P. J., Grunberg, S. M., Gralla, R. J., Warr, D. G., Roila, F., de Wit, R., Chawla, S. P., Carides, A. D., Ianus, J., Elmer, M. E., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.095 · Cited by 779
Maier-Hauff, K., Rothe, R., Scholz, R., Gneveckow, U., Wust, P., Thiesen, B., Feussner, A., von Deimling, A., Waldoefner, N., Felix, R., et al. (2007) · Journal of Neuro-Oncology · doi:10.1007/s11060-006-9195-0 · Cited by 775 · cited 1×
“They concluded that thermotherapy using magnetic NPs was tolerated well by all patients with minor or no side effects (Maier-Hauff et al., 2007).”
There’s plenty of room at the bottom
Feynman, R. P. (2011) · Resonance · doi:10.1007/s12045-011-0109-x · Cited by 762
Radiotherapy enhancement with gold nanoparticles
Hainfeld, J. F., Dilmanian, F. A., Slatkin, D. N., & Smilowitz, H. M. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.8.0005 · Cited by 733 · cited 2×
“…the most commonly investigated nanoparticulate radiosensitizers in preclinical models include gold (Botchway et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada…”
The emerging field of RNA nanotechnology
Guo, P. (2010) · Nature Nanotechnology · doi:10.1038/nnano.2010.231 · Cited by 718 · cited 1×
“Accordingly, the field of RNA nanotechnology is emerging (Chen et al., 2015a; Guo, 2010; Roh, 2012; Shukla et al., 2011).”
Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine
Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G. D., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 710
Nanonization strategies for poorly water-soluble drugs
Chen, H., Khemtong, C., Yang, X., Chang, X., & Gao, J. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2010.02.009 · Cited by 642
Pluronic® block copolymers for overcoming drug resistance in cancer
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 636
Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents
Busquets, M. A., Estelrich, J., & Sánchez-Martín, M. J. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s76501 · Cited by 622 · cited 2×
“…unique among NPs include surface plasmon resonance in some metal particles and superparamagnetism in magnetic materials (Chen et al., 2015d; Estelrich et al., 2015; Hussein-Al-Ali et al., 2014; Skopalik et al., 2014), which makes them desirable as a magnetictargeting tool for medical…”
Silver Nanoparticles Inhibit Hepatitis B virus Replication
Lu, L., Sun, R. W.-Y., Chen, R., Hui, C.-K., Ho, C.-M., Luk, J. M., Lau, G. K., & Che, C.-M. (2008) · Antiviral Therapy · doi:10.1177/135965350801300210 · Cited by 603 · cited 2×
“, 2005), hepatitis B virus (Lu et al., 2008), respiratory syncytial virus (Taylor et al.”
In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight
Dahlman, J. E., Barnes, C., Khan, O. F., Thiriot, A., Jhunjunwala, S., Shaw, T. E., Xing, Y., Sager, H. B., Sahay, G., Speciner, L., et al. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.84 · Cited by 592
Nanosilver particles in medical applications: synthesis, performance, and toxicity
Xing, M., Ge, L., Wang, M., Li, Q., Li, X., & Ouyang, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55015 · Cited by 582 · cited 4×
“It has been reported that Ag NPs have higher antiviral activity than Ag ions, due to species differences as they release Ag0 (atomic) and Ag+ (ionic) clusters, whereas Ag salts release Ag+ only (Ge et al., 2014).”
InfluentialOptical Coherence Tomography for Optical Biopsy: Properties and Demonstration of Vascular Pathology
Brezinski, M. E., Tearney, G. J., Bouma, B. E., Izatt, J. A., Hee, M. R., Swanson, E. A., Southern, J. F., & Fujimoto, J. G. (1996) · Circulation · doi:10.1161/01.cir.93.6.1206 · Cited by 566 · cited 1×
“A new type optical coherence tomography (OCT) with gold nanoshells can improve the detection of certain diseases (Agrawal et al., 2006; Brezinski et al., 1996; Loo et al., 2004).”
Nanomedicines: addressing the scientific and regulatory gap
Tinkle, S., McNeil, S. E., Mühlebach, S., Bawa, R., Borchard, G., Barenholz, Y. (., Tamarkin, L., & Desai, N. (2014) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12403 · Cited by 546
Kunzmann, A., Andersson, B., Thurnherr, T., Krug, H., Scheynius, A., & Fadeel, B. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2010.04.007 · Cited by 527 · cited 1×
“In addition, nanomaterials have a broad application prospect in the medical field (Fan and Alexeeff, 2010; Fu, 2014; Kunzmann et al., 2011; Zhao and Castranova, 2011).”
Emerich, D. F., & Thanos, C. G. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.4.655 · Cited by 510
Phase III and submission failures: 2007–2010
Arrowsmith, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3375 · Cited by 480 · cited 1×
“In phase III failures of clinical trials reported between 2007 and 2010, Thomson Reuters Life Science Consulting found that 21% of the failures were due to safety issues (Arrowsmith, 2011).”
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
Dong, S. (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s2824 · Cited by 464 · cited 1×
“…2015; Partha and Conyers, 2009; Tautzenberger et al., 2012; Tonelli et al., 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging (Cao et al., 2014; Peng et al., 2008; Sheng et al., 2014; Yi et al., 2014), etc., which bring many benefits to humans.”
PEG conjugates in clinical development or use as anticancer agents: An overview
Pasut, G., & Veronese, F. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.010 · Cited by 457
Polymer conjugates: nanosized medicines for treating cancer
Vicent, M. J., & Duncan, R. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.11.006 · Cited by 443
Sun, R. W.-Y., Chen, R., Chung, N. P.-Y., Ho, C.-M., Lin, C.-L. S., & Che, C.-M. (2005) · Chemical Communications · doi:10.1039/b510984a · Cited by 440 · cited 3×
“Research evidence shows that AgNPs possess antiviral activity against HIV-1 (Lara et al., 2010; Sun et al., 2005), hepatitis B virus (Lu et al.”
Quantum-size effects in the thermodynamic properties of metallic nanoparticles
Volokitin, Y., Sinzig, J., de Jongh, L. J., Schmid, G., Vargaftik, M. N., & Moiseevi, I. I. (1996) · Nature · doi:10.1038/384621a0 · Cited by 421 · cited 1×
“Early in 1996, Volokitin et al. (1996) had already confirmed that quantum size strongly influences the thermodynamic properties of metallic NPs.”
Regulatory aspects on nanomedicines
Sainz, V., Conniot, J., Matos, A. I., Peres, C., Zupanǒiǒ, E., Moura, L., Silva, L. C., Florindo, H. F., & Gaspar, R. S. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.023 · Cited by 417
Guo, Y., Wang, D., Song, Q., Wu, T., Zhuang, X., Bao, Y., Kong, M., Qi, Y., Tan, S., & Zhang, Z. (2015) · ACS Nano · doi:10.1021/acsnano.5b01042 · Cited by 413 · cited 3×
“…polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011; Chavez-Santoscoy et al., 2012), polymeric (Guo et al., 2015b; Vicente et al., 2013), chitosan (Danesh-Bahreini et al., 2011; Doavi et al., 2016; Hunsawong et al., 2015) and silica NPs (Mahony…”
A Near Infrared Light Triggered Hydrogenated Black TiO2 for Cancer Photothermal Therapy
Ren, W., Yan, Y., Zeng, L., Shi, Z., Gong, A., Schaaf, P., Wang, D., Zhao, J., Zou, B., Yu, H., et al. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500273 · Cited by 409 · cited 1×
“NIR fluorescent NPs are also considered promising candidates for use as contrast agents for tumor detection (Ren et al., 2015).”
Self-citationJohannsen, M., Gneveckow, U., Taymoorian, K., Thiesen, B., Waldöfner, N., Scholz, R., Jung, K., Jordan, A., Wust, P., & Loening, S. A. (2007) · International Journal of Hyperthermia · doi:10.1080/02656730601175479 · Cited by 382 · cited 2×
“At a median follow-up of 17.5months (3–24), no systemic toxicity was observed ( Johannsen et al., 2007).”
Odyssey of a cancer nanoparticle: From injection site to site of action
Nichols, J. W., & Bae, Y. H. (2012) · Nano Today · doi:10.1016/j.nantod.2012.10.010 · Cited by 364
Nanotechnology-based approaches in anticancer research
Kamal, M. A., Jabir NR, N., Tabrez, Ashraf, Shakil, & Damanhouri (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33838 · Cited by 363 · cited 2×
“…al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et al., 2014; Wang et al., 2013), gene therapy (Rodriguez-Gascon et al., 2014), antibacterial agents (Amrol, 2007; Seil…”
Nano/Microfluidics for diagnosis of infectious diseases in developing countries
Lee, W. G., Kim, Y.-G., Chung, B. G., Demirci, U., & Khademhosseini, A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.016 · Cited by 357 · cited 2×
“Metal NPs dispersed on an oxide support often show a much higher catalytic activity than the single-component NPs (Lee et al., 2010b).”
Breaking Down the Barriers to Precision Cancer Nanomedicine
von Roemeling, C., Jiang, W., Chan, C. K., Weissman, I. L., & Kim, B. Y. S. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.07.006 · Cited by 330
Synthetic Tuning of the Catalytic Properties of Au‐Fe3O4 Nanoparticles
Lee, Y., Garcia, M. A., Frey Huls, N. A., & Sun, S. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906130 · Cited by 330 · cited 2×
“Metal NPs dispersed on an oxide support often show a much higher catalytic activity than the single-component NPs (Lee et al., 2010b).”
Clinical toxicities of nanocarrier systems.
Vega-Villa, K. R., Takemoto, J. K., Yáñez, J. A., Remsberg, C. M., Forrest, M. L., & Davies, N. M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.007 · Cited by 325 · cited 1×
“At the same time, studies on the biosafety of nanomaterials have been soaring in recent years (Vega-Villa et al., 2008).”
Sakamoto, Y., Nakae, D., Fukumori, N., Tayama, K., Maekawa, A., Imai, K., Hirose, A., Nishimura, T., Ohashi, N., & Ogata, A. (2009) · The Journal of Toxicological Sciences · doi:10.2131/jts.34.65 · Cited by 320 · cited 1×
“Limited results are reported for the carcinogenicity of multiwalled carbon nanotubes in animal experiments after intraperitoneal injections (Sakamoto et al., 2009), but no data are available for lung inhalation exposure.”
Kwatra, D., Venugopal, A., & Anant, S. (2013) · Translational Cancer Research · doi:10.21037/1550 · Cited by 293
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.029 · Cited by 292
PEG-uricase in the management of treatment-resistant gout and hyperuricemia
Sherman, M. R., Saifer, M. G. P., & Perez-Ruiz, F. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.011 · Cited by 291
Silver/poly (lactic acid) nanocomposites: preparation, characterization, and antibacterial activity
Shameli, K., Ahmad, M. B., Darroudi, M., Rahman, R. A., Jokar, M., Yunis, W. M. Z. W., & Ibrahim, N. A. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s12007 · Cited by 291
A Self‐Assembled Albumin‐Based Nanoprobe for In Vivo Ratiometric Photoacoustic pH Imaging
Chen, Q., Liu, X., Chen, J., Zeng, J., Cheng, Z., & Liu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503194 · Cited by 286 · cited 4×
“Chen et al. (2015b) designed a photoacoustic nanoprobe for pH detection.”
InfluentialDutta, P. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24019 · Cited by 285 · cited 1×
“Nagy et al. (2011) evaluated the antibacterial properties of Ag NPs embedded within a zeolite membrane (Ag NP ZM).”
Toxicology of Nanomaterials Used in Nanomedicine
Zhao, J., & Castranova, V. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.615113 · Cited by 280 · cited 5×
“Despite the many proposed advantages of nanomaterials, increasing concerns have been expressed on human biosafety (Zhao and Castranova, 2011).”
InfluentialSelf-citationBiomedical applications of functionalized fullerene-based nanomaterials
Conyers, J. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s5964 · Cited by 274
Physiology and Pharmacology of Erythropoietin
Jelkmann, W. (2013) · Transfusion Medicine and Hemotherapy · doi:10.1159/000356193 · Cited by 273
Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls
Lee, J., Chatterjee, D. K., Lee, M. H., & Krishnan, S. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.006 · Cited by 271 · cited 2×
“…in preclinical models include gold (Botchway et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al., 2015; Klein et…”
Reducing infections through nanotechnology and nanoparticles
Webster, T. J., & Taylor (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22021 · Cited by 267
Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis
Will, O., Purkayastha, S., Chan, C., Athanasiou, T., Darzi, A. W., Gedroyc, W., & Tekkis, P. P. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70537-4 · Cited by 260 · cited 1×
“Will et al. (2006) assessed the diagnostic precision of MRI with Ferumoxtran-10, an ultrasmall superparamagnetic iron oxide NPs, used as a contrast agent for the diagnosis of lymph node metastases.”
Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes
Sargent, L. M., Porter, D. W., Staska, L. M., Hubbs, A. F., Lowry, D. T., Battelli, L., Siegrist, K. J., Kashon, M. L., Mercer, R. R., Bauer, A. K., et al. (2014) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-11-3 · Cited by 256
Polymer therapeutics as nanomedicines: new perspectives
Duncan, R. (2011) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.05.507 · Cited by 254
Therapeutic gold, silver, and platinum nanoparticles
Yamada, M., Foote, M., & Prow, T. W. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1322 · Cited by 245 · cited 4×
“, 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al.”
InfluentialTherapeutic Nanoparticles in Clinics and Under Clinical Evaluation
Schütz, C. A., Juillerat-Jeanneret, L., Mueller, H., Lynch, I., & Riediker, M. (2013) · Nanomedicine · doi:10.2217/nnm.13.8 · Cited by 242 · cited 7×
“As Schütz et al. (2013) pointed out: “Care must be taken to ensure biocompatibility of the carrier or therapeutic nanomaterials and to ensure that their intrinsic toxicity does not overtake their benefits.””
InfluentialNanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
Rupp, R. E., Rosenthal, S. L., & Stanberry, L. R. (2007) · PubMed · Cited by 235
Near-infrared fluorescent probes in cancer imaging and therapy: an emerging field
Yi, X., Wang, F., Qin, W., Yang, X., & Yuan, J. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s60206 · Cited by 233 · cited 1×
“…2015; Partha and Conyers, 2009; Tautzenberger et al., 2012; Tonelli et al., 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging (Cao et al., 2014; Peng et al., 2008; Sheng et al., 2014; Yi et al., 2014), etc., which bring many benefits to humans.”
Epaxal®: a virosomal vaccine to prevent hepatitis A infection
Bovier, P. A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1141 · Cited by 233
Jung, C. W. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(95)00023-a · Cited by 226
Neuropsychiatric applications of DTI – a review
Lim, K. O., & Helpern, J. A. (2002) · NMR in Biomedicine · doi:10.1002/nbm.789 · Cited by 225 · cited 1×
“…can pass through the biological barriers of the human body, such as the blood–brain barrier, blood–eye barrier, as well as other cell biological membrane barriers, allowing drugs to reach the lesions, and increasing efficacy (Lim and Helpern, 2002; Patravale et al., 2004; Stowe et al., 2012).”
Microtechnologies and nanotechnologies for single-cell analysis
Andersson, H., & van den Berg, A. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.01.004 · Cited by 217
Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples
Haun, J. B., Castro, C. M., Wang, R., Peterson, V. M., Marinelli, B. S., Lee, H., & Weissleder, R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002048 · Cited by 214 · cited 1×
“A team of investigators from the Massachusetts General Hospital and Harvard Medical School have developed a fast, portable molecular imaging device in combination with magnetic NPs and a smartphone (Haun et al., 2011).”
In vivo human time-exposure study of orally dosed commercial silver nanoparticles
Munger, M. A., Radwański, P., Hadlock, G. C., Stoddard, G., Shaaban, A. M., Falconer, J. L., Grainger, D. W., & Deering‐Rice, C. E. (2013) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2013.06.010 · Cited by 212 · cited 3×
“With the rapid development of nanotechnology, Ag nanoproducts have broadened their application as an antibacterial, antiviral and anti-inflammatory therapy (Munger et al., 2014).”
InfluentialMastorakos, P., da Silva, A. L., Chisholm, J., Song, E., Choi, W. K., Boyle, M. P., Morales, M. M., Hanes, J., & Suk, J. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502281112 · Cited by 210 · cited 2×
“Applications in gene therapy of cancer As stated above, gene therapy has emerged as an alternative for the treatment of diseases (Mastorakos et al., 2015).”
Xiang, D., Zheng, C.-L., Zheng, Y., Li, X., Yin, J., O’ Conner, M., Marappan, M., Miao, Y., Xiang, B., Duan, W., et al. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s53622 · Cited by 206 · cited 1×
“Research evidence shows that AgNPs possess antiviral activity against HIV-1 (Lara et al., 2010; Sun et al., 2005), hepatitis B virus (Lu et al., 2008), respiratory syncytial virus (Taylor et al., 2005) and human influenza virus (Xiang et al., 2013).”
Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds
Rivera Gil, P., Hühn, D., del Mercato, L. L., Sasse, D., & Parak, W. J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.01.009 · Cited by 202
Venkatraman, G., Ramya, Shruthilaya, Akila, Ganga, Kumar, S., Yoganathan, Santosham, R., & Ponraju (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s25182 · Cited by 195 · cited 1×
“Nanomaterials have been investigated in the medical field for drugs (Cao et al., 2014; Ranganathan et al., 2012; Tan et al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et…”
Deposition of silver nanoparticles on titanium surface for antibacterial effect
Juan, L. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s8810 · Cited by 195
Ultrastable synergistic tetravalent RNA nanoparticles for targeting to cancers
Haque, F., Shu, D., Shu, Y., Shlyakhtenko, L. S., Rychahou, P. G., Mark Evers, B., & Guo, P. (2012) · Nano Today · doi:10.1016/j.nantod.2012.06.010 · Cited by 193 · cited 1×
“Scientists at the University of Kentucky have developed thermodynamically stable X-shaped RNA NPs for carrying therapeutic RNA motifs by selfassembly of re-engineered small RNA fragments, which is considered useful for cancer treatments at the RNA and DNA level (Haque et al., 2012).”
Baan, R. A. (2007) · Inhalation Toxicology · doi:10.1080/08958370701497903 · Cited by 192
Nano-encapsulation of azole antifungals: Potential applications to improve oral drug delivery
Pandey, R., Ahmad, Z., Sharma, S., & Khuller, G. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.027 · Cited by 192 · cited 2×
“(6) Compared with drug administration alone, drugs delivered by nanocarriers can achieve targeted drug therapy with high bioavailability (Pandey et al., 2005) and reduce the side effects of drugs accompanying decreases in drug dosage (Bishwajitsutradhar and Amin, 2014) and treatment cost (Master and Sen Gupta, 2012).”
Polymer therapeutics: Clinical applications and challenges for development
Vicent, M. J., Ringsdorf, H., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.08.001 · Cited by 183
Development of polymeric micelles for targeting intractable cancers
Nishiyama, N., Matsumura, Y., & Kataoka, K. (2016) · Cancer Science · doi:10.1111/cas.12960 · Cited by 180 · cited 1×
“Moreover, a large proportion of the soft NPs are composed of liposomal and polymer-conjugated formulations (see Table 1) (Ko, 2016; Nishiyama et al., 2016; Zatsepin et al., 2016).”
Nanoparticles and their potential for application in bone
Tautzenberger, A., Kovtun, & Ignatius (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s34127 · Cited by 180 · cited 2×
“…agents (du Toit et al., 2010; Mahajan et al., 2012; Parboosing et al., 2012), tissue engineering (Mazaheri et al., 2015; Partha and Conyers, 2009; Tautzenberger et al., 2012; Tonelli et al., 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging…”
Lara, H. H., Ixtepan-Turrent, L., Garza-Treviño, E. N., & Rodriguez-Padilla, C. (2010) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-8-15 · Cited by 179 · cited 3×
“Research evidence shows that AgNPs possess antiviral activity against HIV-1 (Lara et al., 2010; Sun et al., 2005), hepatitis B virus (Lu et al.”
Berberine hydrochloride: anticancer activity and nanoparticulate delivery system
Tan, W., Li, Chen, M., & Wang, Y. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s22683 · Cited by 175 · cited 2×
“Nanomaterials have been investigated in the medical field for drugs (Cao et al., 2014; Ranganathan et al., 2012; Tan et al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al.”
Self-citationConcept and Clinical Evaluation of Carrier-Mediated Anticancer Agents
Zamboni, W. C. (2008) · The Oncologist · doi:10.1634/theoncologist.2007-0180 · Cited by 173
Piktel, E., Niemirowicz, K., Wątek, M., Wollny, T., Deptuła, P., & Bucki, R. (2016) · Journal of Nanobiotechnology · doi:10.1186/s12951-016-0193-x · Cited by 171 · cited 2×
“number of them have been introduced into clinical trials (Piktel et al., 2016).”
Clinical Developments in Nanotechnology for Cancer Therapy
Heidel, J. D., & Davis, M. E. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0178-7 · Cited by 170
Optical properties of nanostructured materials: a review
Flory, F. (2011) · Journal of Nanophotonics · doi:10.1117/1.3609266 · Cited by 169 · cited 1×
“The coupling between several metallic NPs can induce a field enhancement in the surrounding media, which can increase phenomena such as scattering, absorption, luminescence or Raman scattering (Berginc, 2011).”
Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4
Ren, Y., Cheung, H. W., von Maltzhan, G., Agrawal, A., Cowley, G. S., Weir, B. A., Boehm, J. S., Tamayo, P., Karst, A. M., Liu, J. F., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003778 · Cited by 168 · cited 1×
“Ren et al. (2012) found that most of the tumors can be eliminated in ovarian tumor-bearing mice by using RNAi (RNA interfere) NP treatment.”
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy.
Su, X., Liu, P., Wu, H., & Gu, N. (2014) · PubMed · doi:10.7497/j.issn.2095-3941.2014.02.003 · Cited by 167 · cited 2×
“Along with the rapid development of nanotechnology, the potential value of NPs as novel radiosensitizers in radiation therapy has been investigated in recent years (Su et al., 2014).”
Stowe, T. R., Wilkinson, C. J., Iqbal, A., & Stearns, T. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-02-0134 · Cited by 165 · cited 2×
“(5) Nanometer drug carriers can pass through the biological barriers of the human body, such as the blood–brain barrier, blood–eye barrier, as well as other cell biological membrane barriers, allowing drugs to reach the lesions, and increasing efficacy (Lim and Helpern, 2002; Patravale et al., 2004; Stowe et al., 2012…”
Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside
Zatsepin (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s106625 · Cited by 162 · cited 1×
“Moreover, a large proportion of the soft NPs are composed of liposomal and polymer-conjugated formulations (see Table 1) (Ko, 2016; Nishiyama et al., 2016; Zatsepin et al., 2016).”
Hsu, S.-H., Liu, Dai, S., & Fu (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s14572 · Cited by 162
EGF Receptor-Targeted Nanocarriers for Enhanced Cancer Treatment
Master, А. M., & Gupta, A. S. (2012) · Nanomedicine · doi:10.2217/nnm.12.160 · Cited by 161
Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems
Sharma, S., Mukkur, T. K. S., Benson, H. A. E., & Chen, Y. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21493 · Cited by 160 · cited 1×
“The disadvantages of nanovaccines may include difficulty in reproducibility of formulation during manufacturing (Sharma et al., 2009) and potentially toxicity induced by a prolonged clearance time of the NPs in the body.”
Banerjee, R. (2009) · Nanomedicine · doi:10.2217/nnm.09.11 · Cited by 160
Potential and problems in ultrasound-responsive drug delivery systems
Lu, C.-T., Zhao, Y.-Z., Ge, S.-P., Jin, Y.-G., & Du, L.-N. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s43589 · Cited by 154 · cited 2×
“Nanomaterials have been investigated in the medical field for drugs (Cao et al., 2014; Ranganathan et al., 2012; Tan et al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al.”
Dendritic cell-based nanovaccines for cancer immunotherapy
Paulis, L. E. M., Mandal, S., Kreutz, M., & Figdor, C. G. (2013) · Current Opinion in Immunology · doi:10.1016/j.coi.2013.03.001 · Cited by 153 · cited 2×
“, 2013) and possibly promising chronic disease treatments, such as cancers (Nandedkar, 2009; Paulis et al., 2013), HIV (Vela Ramirez et al.”
Anti-HIV-1 nanotherapeutics: promises and challenges for the future
Mahajan, S. D., Law, W., Aalinkeel, Reynolds, Nair, Sykes, Yong, K., Roy, Prasad, P. N., & Schwartz, S. A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s25871 · Cited by 152 · cited 2×
“, 2014), antibacterial agents (Amrol, 2007; Seil and Webster, 2012; Taylor and Webster, 2011), antiviral agents (du Toit et al., 2010; Mahajan et al., 2012; Parboosing et al., 2012),”
Nanotechnology and the Treatment of HIV Infection
Parboosing, R., Maguire, G. E. M., Govender, P., & Kruger, H. G. (2012) · Viruses · doi:10.3390/v4040488 · Cited by 150 · cited 2×
“, 2014), antibacterial agents (Amrol, 2007; Seil and Webster, 2012; Taylor and Webster, 2011), antiviral agents (du Toit et al., 2010; Mahajan et al., 2012; Parboosing et al., 2012),”
Nanovaccines and their mode of action
Zaman, M., Good, M. F., & Tóth, I. (2013) · Methods · doi:10.1016/j.ymeth.2013.04.014 · Cited by 148 · cited 3×
“Nanovaccine is a novel approach for vaccinations (Zaman et al., 2013).”
InfluentialSafety of Ferumoxytol in Patients With Anemia and CKD
Singh, A. K., Patel, T. V., Hertel, J., Bernardo, M. V., Kausz, A., & Brenner, L. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.08.001 · Cited by 147
Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145
Carrillo-Conde, B., Song, E.-H., Chavez-Santoscoy, A., Phanse, Y., Ramer-Tait, A. E., Pohl, N. L. B., Wannemuehler, M. J., Bellaire, B. H., & Narasimhan, B. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200213r · Cited by 144 · cited 2×
“…(Ghaffar et al., 2014; Hu et al., 2014; Marasini et al., 2016), polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011; Chavez-Santoscoy et al., 2012), polymeric (Guo et al., 2015b; Vicente et al., 2013), chitosan (Danesh-Bahreini et al.,…”
Surface-Enhanced Raman Scattering-Active Nanostructures and Strategies for Bioassays
Jun, B.-H., Kim, G., Noh, M. S., Kang, H., Kim, Y.-K., Cho, M.-H., Jeong, D. H., & Lee, Y.-S. (2011) · Nanomedicine · doi:10.2217/nnm.11.123 · Cited by 142
Optimizing efficacy of amphotericin B through nanomodification
Vyas, S. P., & Gupta, S. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.417 · Cited by 137
Nanocarriers for Anticancer Drugs - New Trends in Nanomedicine
Drbohlavová, J., Chomoucká, J., Adam, V., Ryvolová, M., Eckschlager, T., Hubálek, J., & Kizek, R. (2013) · Current Drug Metabolism · doi:10.2174/1389200211314050005 · Cited by 136 · cited 1×
“Drug delivery focuses on maximizing bioavailability both at specific places in the body and over a period of time, which can potentially be achieved through molecular targeting by nanoengineered carriers (Drbohlavova et al., 2013).”
Retinoic acid syndrome: a review
Patatanian, E., & Thompson, D. F. (2008) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2008.00935.x · Cited by 135
Superparamagnetic Iron Oxide Nanoparticles as Novel X-ray Enhancer for Low-Dose Radiation Therapy
Klein, S., Sommer, A., Distel, L. V., Hazemann, J., Kroener, W., Neuhuber, W., Müller, P., Proux, O., & Kryschi, C. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp5026224 · Cited by 134 · cited 1×
“…et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al., 2015; Klein et al., 2014; Sun et al., 2016; Zhao et al., 2012) NPs.”
Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics
Marchal, S., Hor, A. E., Millard, M., Gillon, V., & Bezdetnaya, L. (2015) · Drugs · doi:10.1007/s40265-015-0453-3 · Cited by 131 · cited 2×
“As Marchal et al. (2015) pointed out: “The hope raised by promising preclinical studies has often resulted in disappointment when nanomedicines have been applied in patients.””
Dyondi, Webster, & Banerjee, R. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s37953 · Cited by 131 · cited 1×
“Dyondi et al. (2013) tested gellan xanthan gels along with chitosan NPs of basic fibroblast growth factor, and bone morphogenetic protein 7 in a dual growth factor delivery system to promote the differentiation of human fetal osteoblasts.”
Duraisamy, S., Murugan, K., Balakrishnan, S., & Al-Sohaibani, S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61779 · Cited by 131 · cited 2×
“Although Ag NPs alone are strong bactericidal agents (Murugan et al., 2014), they are also cytotoxic (Ge et al., 2014).”
Singh, R., Swanner, J., Mims, J., Akman, S., Furdui, C., Torti, S., & Carroll, D. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s80349 · Cited by 130 · cited 2×
“, 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al.”
Nanoengineering of vaccines using natural polysaccharides
Cordeiro, A. S., Alonso, M. J., & de la Fuente, M. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.05.010 · Cited by 129 · cited 4×
“…which are in the experimental stage at present, including liposomes (Ghaffar et al., 2014; Hu et al., 2014; Marasini et al., 2016), polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011; Chavez-Santoscoy et al., 2012), polymeric (Guo et al.,…”
InfluentialPeppas, N. A., & Kavimandan, N. J. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.04.014 · Cited by 125
Challenges of clinical translation in nanomedicine: A qualitative study
Satalkar, P., Elger, B. S., Hunziker, P., & Shaw, D. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.12.376 · Cited by 124 · cited 1×
“However, the transition probability might be low because clinical translation in nanomedicine is a long, arduous, resource intensive process (Satalkar et al., 2016).”
Bhana, S., Lin, G., Wang, L., Starring, H., Mishra, S. R., Liu, G., & Huang, X. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b02741 · Cited by 123 · cited 1×
“…et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al., 2015; Klein et al., 2014; Sun et al., 2016; Zhao et al., 2012) NPs.”
Resende, R. R., Tonelli, F. M. P., Santos, A. K., Gomes, K. N., Lorençon, E., Ladeira, L. O., & Guatimosim, S. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s33612 · Cited by 120 · cited 3×
“…Mahajan et al., 2012; Parboosing et al., 2012), tissue engineering (Mazaheri et al., 2015; Partha and Conyers, 2009; Tautzenberger et al., 2012; Tonelli et al., 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging (Cao et al., 2014; Peng et al.,…”
Sun, L., Joh, D. Y., Al-Zaki, A., Stangl, M., Murty, S., Davis, J. J., Baumann, B. C., Alonso-Basanta, M., Kao, G. D., Tsourkas, A., et al. (2016) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2016.2173 · Cited by 119 · cited 1×
“…et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al., 2015; Klein et al., 2014; Sun et al., 2016; Zhao et al., 2012) NPs.”
Shukla, G. C., Haque, F., Tor, Y., Wilhelmsson, L. M., Toulmé, J., Isambert, H., Guo, P., Rossi, J. J., Tenenbaum, S. A., & Shapiro, B. A. (2011) · ACS Nano · doi:10.1021/nn200989r · Cited by 118 · cited 1×
“Accordingly, the field of RNA nanotechnology is emerging (Chen et al., 2015a; Guo, 2010; Roh, 2012; Shukla et al., 2011).”
Rajala, A., Wang, Y., Zhu, Y., Ranjo-Bishop, M., Ma, J.-X., Mao, C., & Rajala, R. V. S. (2014) · Nano Letters · doi:10.1021/nl502275s · Cited by 117 · cited 1×
“Recently, there have been promising results achieved with LPD NPs to deliver functional genes and microRNA to treat retinal diseases (Rajala et al., 2014; Takahashi et al., 2015).”
Self-citationQuantitative evaluation of optical coherence tomography signal enhancement with gold nanoshells
Agrawal, A., Huang, S., Lin, A. W. H., Lee, M., Barton, J. K., Drezek, R. A., & Pfefer, T. J. (2006) · Journal of Biomedical Optics · doi:10.1117/1.2339071 · Cited by 116 · cited 1×
“A new type optical coherence tomography (OCT) with gold nanoshells can improve the detection of certain diseases (Agrawal et al., 2006; Brezinski et al., 1996; Loo et al., 2004).”
Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics
Chen, J., Shao, R., Zhang, X. D., & Chen, C. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s45429 · Cited by 116 · cited 2×
“, 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging (Cao et al.”
Kumar, R., Chen, M.-H., Parmar, V. S., Samuelson, L. A., Kumar, J., Nicolosi, R. J., Yoganathan, S., & Watterson, A. C. (2004) · Journal of the American Chemical Society · doi:10.1021/ja039651w · Cited by 116 · cited 1×
“Studies have shown that the anti-inflammatory effect of nanopreparations of aspirin is two times greater than ordinary aspirin at the same dose (Rajesh et al., 2004).”
Mohammadi‐Samani, S., Bahraini, D., Shokri, Kamali‐Sarvestani, E., Baezegar-Jalali, M., & Samiei, A. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s16805 · Cited by 115
Nanomedicine: promises and challenges for the future of public health
Brenner, S. (2010) · International Journal of Nanomedicine · doi:10.2147/ijn.s13816 · Cited by 114 · cited 1×
“Nanotechnology is considered one of three major technologies of the twenty-first century (Pautler and Brenner, 2010; Reese, 2013), which is a technology of nanometer scale used to control material structure.”
Spadavecchia, J., Movia, D., Moore, C., Maguire, C. M., Moustaoui, H., Casale, S., Volkov, Y., & Prina‐Mello, A. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s97476 · Cited by 113
Ishihara, T., Kubota, T., Choi, T., & Higaki, M. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.150276 · Cited by 110 · cited 1×
“Nanomaterials have many other applications in the field of nanomedicine, such as NPs encapsulating hormone drugs (Ayano et al., 2012; Hariri et al., 2015; Ishihara et al., 2009a,b; Santander-Ortega et al., 2009; Silva J. Appl.”
Recent advances on biocompatible and biodegradable nanoparticles as gene carriers
Mokhtarzadeh, A., Alibakhshi, A., Yaghoobi, H., Hashemi, M., Hejazi, M., & Ramezani, M. (2016) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2016.1169269 · Cited by 110 · cited 2×
“…gene circulation time, prevented gene degradation, passive targeting by using the enhanced permeability and retention effect, and possibly modulating polymer structure to obtain desirable therapeutic efficacy, are considered as the most promising gene delivery vehicles (Mokhtarzadeh et al., 2016).”
Multifunctional materials for bone cancer treatment
Ficai, A., Marques, C. F., Ferreira, J. M. F., Andronescu, E., Ficai, D., & Sönmez, M. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s55943 · Cited by 107 · cited 2×
“…al., 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et al., 2014; Wang et al., 2013), gene therapy (Rodriguez-Gascon et al., 2014), antibacterial agents (Amrol, 2007; Seil and Webster, 2012;…”
Nanovaccines: recent developments in vaccination
Nandedkar, T. D. (2009) · Journal of Biosciences · doi:10.1007/s12038-009-0114-3 · Cited by 102
Liposomes as Nanovaccine Delivery Systems
Ghaffar, K., Giddam, A., Zaman, M., Skwarczynski, M., & Toth, I. (2014) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026614666140329232757 · Cited by 101 · cited 2×
“Nanomaterials are frequently evaluated as the nanocarriers for nanovaccines, which are in the experimental stage at present, including liposomes (Ghaffar et al., 2014; Hu et al., 2014; Marasini et al., 2016), polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride…”
Au, K. M., Lu, Z., Matcher, S. J., & Armes, S. P. (2011) · Advanced Materials · doi:10.1002/adma.201103190 · Cited by 100 · cited 1×
“In addition, Au et al. (2011) evaluated a near-infrared (NIR) absorbing contrast agent based on polypyrrole NPs for quantitative OCT studies on tissue phantoms and Mie scattering calculations.”
High chemical reactivity of silver nanoparticles toward hydrochloric acid
Li, L., & Zhu, Y. (2006) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2006.07.059 · Cited by 100 · cited 1×
“As Li and Zhu (2006) reported the high chemical reactivity of silver (Ag) NPs with hydrochloric acid and characterized by X-ray powder diffraction gives direct evidence of the reaction, which has been proven impossible for the bulk Ag.”
Nab-paclitaxel for the treatment of breast cancer: efficacy, safety, and approval
Yamamoto, Y., Kawano, I., & Iwase (2011) · OncoTargets and Therapy · doi:10.2147/ott.s13836 · Cited by 99
Chavez-Santoscoy, A. V., Roychoudhury, R., Pohl, N. L. B., Wannemuehler, M. J., Narasimhan, B., & Ramer‐Tait, A. E. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.027 · Cited by 98 · cited 2×
“…Hu et al., 2014; Marasini et al., 2016), polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011; Chavez-Santoscoy et al., 2012), polymeric (Guo et al., 2015b; Vicente et al., 2013), chitosan (Danesh-Bahreini et al., 2011; Doavi et al., 2016;…”
Gold nanoparticles in radiation research: potential applications for imaging and radiosensitization.
Dorsey, J. F., Sun, L., Joh, D. Y., Witztum, A., Kao, G. D., Alonso‐Basanta, M., Avery, S., Hahn, S. M., Zaki, A. A., & Tsourkas, A. (2013) · PubMed · doi:10.3978/j.issn.2218-676x.2013.08.09 · Cited by 97 · cited 2×
“At present, the most commonly investigated nanoparticulate radiosensitizers in preclinical models include gold (Botchway et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015;…”
Conjugation of quantum dots on carbon nanotubes for medical diagnosis and treatment
Seifalian, A. M., Madani, Shabani, & Dwek, M. V. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s36416 · Cited by 97 · cited 2×
“, 2012), medical diagnosis (Chen et al., 2013; Kang et al., 2015; Madani et al., 2013), medical imaging (Cao et al.”
Cytotoxicity and antibacterial activity of gold-supported cerium oxide nanoparticles
Chen, B., Babu, K. S., Anandkumar, M., Tsai, T. Y., Kao, T. H., & Inbaraj, B. S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s70087 · Cited by 95 · cited 2×
“, 2014), gold-supported cerium oxide NPs (Babu et al., 2014), etc.”
Lipid Nanoparticles for Ocular Gene Delivery
Wang, Y., Rajala, A., & Rajala, R. (2015) · Journal of Functional Biomaterials · doi:10.3390/jfb6020379 · Cited by 93 · cited 4×
“For example, lipid NPs, called liposome protamine/DNA lipoplex (LPD), are used for ocular gene delivery (Wang et al., 2015b).”
InfluentialSelf-citationRoh, C. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s31379 · Cited by 91 · cited 1×
“Accordingly, the field of RNA nanotechnology is emerging (Chen et al., 2015a; Guo, 2010; Roh, 2012; Shukla et al., 2011).”
Leary, S. P., Liu, C. Y., & Apuzzo, M. L. J. (2006) · Neurosurgery · doi:10.1227/01.neu.0000216793.45952.ed · Cited by 87
Abshagen, K., Schrodi, I., Gerber, T., & Vollmar, B. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32237 · Cited by 86 · cited 2×
“These bone materials can promote bone tissue growth and recovery function (Abshagen et al., 2009).”
He, J., Banizs, A., Huang, T., Dryden, K., Berr, S., Stone, J., Nakamoto, R., & Shi, W. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64267 · Cited by 86 · cited 2×
“, 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al.”
Ayano, E., Karaki, M., Ishihara, T., Kanazawa, H., & Okano, T. (2011) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2011.10.003 · Cited by 84 · cited 1×
“Nanomaterials have many other applications in the field of nanomedicine, such as NPs encapsulating hormone drugs (Ayano et al., 2012; Hariri et al., 2015; Ishihara et al., 2009a,b; Santander-Ortega et al., 2009; Silva J. Appl.”
Seiden, M. V., Muggia, F. M., Astrow, A., Matulonis, U. A., Campos, S., Roche, M. R., Sivret, J., Rusk, J., & Barrett, E. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.12.037 · Cited by 84
Chang, T. M. S., Powanda, D., & Yu, W. P. (2003) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.1081/bio-120023155 · Cited by 82 · cited 1×
“Chang et al. (2003) studied a novel nanodimension artificial red blood cell substitute based on ultrathin polyethylene-glycol–polylactide (PEG–PLA) membrane nanocapsules (80–150nm diameter) containing Hb and enzymes.”
Methoxy Polyethylene Glycol-Epoetin Beta
Curran, M. P., & McCormack, P. L. (2008) · Drugs · doi:10.2165/00003495-200868080-00009 · Cited by 81
du Toit, L. C., Pillay, V., & Choonara, Y. E. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.022 · Cited by 81 · cited 1×
“…therapy (Rodriguez-Gascon et al., 2014), antibacterial agents (Amrol, 2007; Seil and Webster, 2012; Taylor and Webster, 2011), antiviral agents (du Toit et al., 2010; Mahajan et al., 2012; Parboosing et al., 2012), tissue engineering (Mazaheri et al., 2015; Partha and Conyers, 2009; Tautzenberger…”
Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles
Rodriguez-Gascon, A., del Pozo-Rodríguez, A., & Solinís, M. A. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s39810 · Cited by 80 · cited 1×
“…et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et al., 2014; Wang et al., 2013), gene therapy (Rodriguez-Gascon et al., 2014), antibacterial agents (Amrol, 2007; Seil and Webster, 2012; Taylor and Webster, 2011), antiviral agents (du Toit et…”
Silva, C. O., Rijo, P. M., Molpeceres, J., Figueiredo, I. V., Ascensão, L., Fernandes, A. S., Roberto, A., & Reis, C. P. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.07.044 · Cited by 80
The role of recent nanotechnology in enhancing the efficacy of radiation therapy
Bergs, J. W. J., Wacker, M. G., Hehlgans, S., Piiper, A., Multhoff, G., Rödel, C. M., & Rödel, F. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.008 · Cited by 77 · cited 2×
“NPs, particularly high atomic number metal NPs such as gold, can either sensitize cancer cells to ionizing radiation via their physicochemical properties, or encapsulate radiation sensitizing agents, thereby protecting them from degradation (Bergs et al., 2015; Kwatra J. Appl.”
Cancer stem cell theory: therapeutic implications for nanomedicine
Huang, J., Wang, X., Wu, & Wang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s38641 · Cited by 76 · cited 2×
“…carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et al., 2014; Wang et al., 2013), gene therapy (Rodriguez-Gascon et al., 2014), antibacterial agents (Amrol, 2007; Seil and Webster, 2012; Taylor and Webster,…”
Is the autophagy a friend or foe in the silver nanoparticles associated radiotherapy for glioma?
Wu, H., Lin, J., Liu, P., Huang, Z., Zhao, P., Jin, H., Wang, C., Wen, L., & Gu, N. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.033 · Cited by 73 · cited 1×
“…et al., 2015; Dorsey et al., 2013; Hainfeld et al., 2008; Her et al., 2015; Jain et al., 2012; Lee et al., 2014; Yamada et al., 2015), Ag (Swanner et al., 2015; Wu et al., 2015; Yamada et al., 2015) and iron oxide (Bhana et al., 2015; Klein et al., 2014; Sun et al., 2016; Zhao et al., 2012) NPs.”
Gold Nanoprobes for Theranostics
Panchapakesan, B., Newell, B., Sethu, P., Rao, M., & Irudayaraj, J. (2011) · Nanomedicine · doi:10.2217/nnm.11.155 · Cited by 73 · cited 1×
“Feedback of biological information will be possible by using in vitro recording devices (Li et al., 2014; Panchapakesan et al., 2011).”
Pillai, G., & Ceballos-Coronel, M. L. (2013) · SAGE Open Medicine · doi:10.1177/2050312113513759 · Cited by 71
Emerging nanotechnology approaches in tissue engineering and regenerative medicine
Kim, Ahn, E. H., Dvir, T., & Kim, D. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s61212 · Cited by 71 · cited 2×
“behavior by nanotechnology is one of many examples demonstrating the significant applications of nanoengineering in biomedicine for the repair or regeneration of tissues and organs (Kim et al., 2014).”
Estradiol in micellar nanoparticles
Simon, J. A. (2006) · Menopause The Journal of The North American Menopause Society · doi:10.1097/01.gme.0000174096.56652.4f · Cited by 70
Biocompatibility and applications of carbon nanotubes in medical nanorobots.
Попов, А. М., Lozovik, Y. E., Fiorito, S., & Yahia, L. (2007) · PubMed Central · Cited by 70
Overview of the role of nanotechnological innovations in the detection and treatment of solid tumors
Pillay, V., Frank, D., Tyagi, C., Tomar, L. K., Choonara, Y. E., du Toit, L. C., Kumar, P., & Penny, C. B. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s50941 · Cited by 68 · cited 2×
“…et al., 2012; Tan et al., 2011; Zhao et al., 2013) and genes carriers (Banizs et al., 2014; Eroglu et al., 2013; Liu et al., 2014), cancer therapy (Frank et al., 2014; Jabir et al., 2012; Marques et al., 2014; Wang et al., 2013), gene therapy (Rodriguez-Gascon et al., 2014), antibacterial agents…”
Nanomedicine applications in orthopedic medicine: state of the art
Simchi, A., Mazaheri, M., Eslahi, N., Ordikhani, F., & Tamjid, E. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s73737 · Cited by 68 · cited 2×
“tissue engineering (Mazaheri et al., 2015; Partha and Conyers, 2009; Tautzenberger et al., 2012; Tonelli et al., 2012), medical diagnosis (Chen et al.”
Electrochemical and optical biosensors based on nanomaterials and nanostructures: A Review
Li, M., Li, R., Li, C. M., & 吴年强 (2011) · Frontiers in Bioscience-Scholar · doi:10.2741/228 · Cited by 68
Advance of the application of nano-controlled release system in ophthalmic drug delivery
Wang, X., Wang, S., & Zhang, Y. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1116025 · Cited by 66
Bianchi, D. W., & Hanson, J. W. (2006) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050600676851 · Cited by 65 · cited 1×
“At the early stages of pregnancy, very small amounts of fetal cells in thematernal blood can be used for genetic defect diagnosis (Bianchi and Hanson, 2006).”
Target-Cell-Specific Fluorescence Silica Nanoprobes for Imaging and Theranostics of Cancer Cells
Li, H., Mu, Y., Lu, J., Wei, W., Wan, Y., & Liu, S. (2014) · Analytical Chemistry · doi:10.1021/ac500173d · Cited by 65
Marasini, N., Giddam, A. K., Ghaffar, K. A., Batzloff, M. R., Good, M. F., Skwarczyński, M., & Tóth, I. (2016) · Nanomedicine · doi:10.2217/nnm.16.36 · Cited by 65 · cited 2×
“…as the nanocarriers for nanovaccines, which are in the experimental stage at present, including liposomes (Ghaffar et al., 2014; Hu et al., 2014; Marasini et al., 2016), polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011; Chavez-Santoscoy et…”
Mahony, D., Cavallaro, A. S., Mody, K. T., Xiong, L., Mahony, T. J., Qiao, S., & Mitter, N. (2014) · Nanoscale · doi:10.1039/c4nr01202j · Cited by 65 · cited 1×
“…(Guo et al., 2015b; Vicente et al., 2013), chitosan (Danesh-Bahreini et al., 2011; Doavi et al., 2016; Hunsawong et al., 2015) and silica NPs (Mahony et al., 2014; Mody et al., 2015), etc. Nanovaccines stimulate the human body’s immune system curing infections, preventing infections and…”
Zheng, Y., Wen, X., Wu, J., Wang, L., Yuan, Z., Peng, J., & Meng, H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84452 · Cited by 63 · cited 1×
“Wen et al. (2015) tested a new method to generate covalent bonds between J. Appl.”
Takahashi, Y., Chen, Q., Rajala, R. V. S., & Ma, J.-X. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.03.010 · Cited by 60 · cited 1×
“Recently, there have been promising results achieved with LPD NPs to deliver functional genes and microRNA to treat retinal diseases (Rajala et al., 2014; Takahashi et al., 2015).”
Nanometer size platinum particle arrays: catalytic and surface chemical properties
Jacobs, P. W., Wind, S. J., Ribeiro, F. H., & Somorjai, G. A. (1997) · Surface Science · doi:10.1016/s0039-6028(96)01268-x · Cited by 57 · cited 1×
“As the particle size gets smaller for nanometer particles, the ratio of the surface atomic number to the total number of atoms increases sharply ( Jacobs et al., 1997).”
LiPuma, J. J., Rathinavelu, S., Foster, B. K., Keoleian, J. C., Makidon, P. E., Kalikin, L. M., & Baker, J. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00691-08 · Cited by 57
Improving “lab-on-a-chip” techniques using biomedical nanotechnology: a review
Gorjikhah, F., Davaran, S., Salehi, R., Bakhtiari, M., Hasanzadeh, A., Panahi, Y., Emamverdy, M., & Akbarzadeh, A. (2016) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1129619 · Cited by 57 · cited 2×
“A lab-on-a-chip is a tool that incorporates numerous laboratory tasks on to a small device, usually only millimeters or centimeters in size (Gorjikhah et al., 2016), where advantage is taken from nanotechnology to enable precise control of the biochemical cellular environment.”
Chitosan-Based Intranasal Vaccine against Escherichia coli O157:H7.
Doavi, T., Gargari, S. L. M., Kamali, M., Amani, J., & Fasihi‐Ramandi, M. (2016) · PubMed Central · doi:10.7508/ibj.2016.02.005 · Cited by 55 · cited 2×
“, 2013), chitosan (Danesh-Bahreini et al., 2011; Doavi et al., 2016; Hunsawong et al., 2015) and silica NPs (Mahony et al.”
A Polymer/Oil Based Nanovaccine as a Single-Dose Immunization Approach
Vicente, S., Díaz-Freitas, B., Peleteiro, M., Sánchez, A., Pascual, D. W., González‐Fernández, Á., & Alonso, M. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062500 · Cited by 54 · cited 2×
“, 2012), polymeric (Guo et al., 2015b; Vicente et al., 2013), chitosan (Danesh-Bahreini et al.”
Srinivasan, D. K., Gandhimathi, C., Venugopal, J. R., Bhaarathy, V., & Ramakrishna, S. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s65335 · Cited by 52 · cited 1×
“Gandhimathi et al. (2014) evaluated the biocomposite nanofibers for the controlled release of biomolecules for skin tissue regeneration.”
Karussis, D., Teitelbaum, D., Sicsic, C., & Brenner, T. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.009 · Cited by 52
Ramirez, J. E. V., Roychoudhury, R., Habte, H. H., Cho, M. W., Pohl, N. L. B., & Narasimhan, B. (2014) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2014.940243 · Cited by 50 · cited 1×
“…body’s immune system curing infections, preventing infections and diseases from spreading (Zaman et al., 2013) and possibly promising chronic disease treatments, such as cancers (Nandedkar, 2009; Paulis et al., 2013), HIV (Vela Ramirez et al., 2014), influenza (Petukhova et al., 2013) and others.”
Enhanced penetration into 3D cell culture using two and three layered gold nanoparticles
Frieboes, H. B., England, C. G., Priest, T., Zhang, G., Sun, X., Patel, D., McNally, L. R., van Berkel, V. H., & Gobin, A. M. (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s51668 · Cited by 49 · cited 1×
“These findings support the concept that tagging tumor necrosis factor (TNF)-gold NPs with tumor vasculature homing peptides have improved antitumor activity, likely because of an active targeting mechanism (Curnis et al., 2015; England et al., 2013).”
Nano Traditional Chinese Medicine: Current Progresses and Future Challenges
Huang, Y., Zhao, Y., Liu, F., & Liu, S. (2015) · Current Drug Targets · doi:10.2174/1389450116666150309122334 · Cited by 48 · cited 1×
“Nanotraditional Chinese medicine refers to bioactive ingredients, bioactive parts, medicinal materials or complex prescriptions, being approximately 100nm in size, which are processed by nanotechnology (Huang et al., 2015).”
Introduction to the Special Issue: Nanomaterials— Toxicology and medical applications
Fu, P. P. (2014) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2014.01.013 · Cited by 47
Mody, K. T., Mahony, D., Cavallaro, A. S., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143507 · Cited by 47 · cited 1×
“…Vicente et al., 2013), chitosan (Danesh-Bahreini et al., 2011; Doavi et al., 2016; Hunsawong et al., 2015) and silica NPs (Mahony et al., 2014; Mody et al., 2015), etc. Nanovaccines stimulate the human body’s immune system curing infections, preventing infections and diseases from spreading…”
A novel and efficient nicotine vaccine using nano-lipoplex as a delivery vehicle
Hu, Y. Y., Zheng, H., Huang, W. C., & Zhang, C. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26635 · Cited by 47 · cited 2×
“…evaluated as the nanocarriers for nanovaccines, which are in the experimental stage at present, including liposomes (Ghaffar et al., 2014; Hu et al., 2014; Marasini et al., 2016), polysaccharide (Cordeiro et al., 2015; Vicente et al., 2014), polyanhydride (Carrillo-Conde et al., 2011;…”
Ishihara, T., Kubota, T., Choi, T., Takahashi, M., Ayano, E., Kanazawa, H., & Higaki, M. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.001 · Cited by 47 · cited 1×
“Nanomaterials have many other applications in the field of nanomedicine, such as NPs encapsulating hormone drugs (Ayano et al., 2012; Hariri et al., 2015; Ishihara et al., 2009a,b; Santander-Ortega et al., 2009; Silva J. Appl.”
Liu, Z., Chen, N., Dong, C., Li, W., Guo, W., Wang, H., Wang, S., Tan, J., Tu, Y., & Chang, J. K. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b05406 · Cited by 47 · cited 2×
“Liu et al. (2015b) developed an NIR fluorescence nanoprobe by coating CuInS2/ZnS quantum dots with an amphiphilic bioconjugate and investigated the feasibility of the constructed NIR fluorescence probe in vivo imaging.”
Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
Choi, M., Al‐Hajeili, M., & Azmi, A. S. (2014) · OncoTargets and Therapy · doi:10.2147/ott.s40705 · Cited by 46 · cited 2×
“NP albumin-bound paclitaxel (nab-paclitaxel) (Abraxane®) is a colloidal suspension of 130 nm particles homogenized in human serum albumin bound to paclitaxel (Al-Hajeili et al., 2014), which has been approved for the treatment of metastatic breast cancer, based on a phase III clinical trial in 460 patients.”
Wetzler, M., Thomas, D. A., Wang, E. S., Shepard, R. C., Ford, L. A., Heffner, T. L., Parekh, S. S., Andreeff, M., O'Brien, S. M., & Kantarjian, H. M. (2013) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2013.03.015 · Cited by 45
Bhatti, A., Mehmood, S., Rehman, M. A., Mirza, B., & Ismail, H. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s83356 · Cited by 45 · cited 2×
“Many other metal or metal compound NPs also show antibacterial activity, such as ZnO NPs (Mehmood et al., 2015), TiO2 nanotubes (Liu et al.”
Cited by
Drug Combinations in Breast Cancer Therapy
Fisusi, F. A., & Akala, E. O. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190122111224 · Cited by 449
Nanocrystals: a perspective on translational research and clinical studies
Jarvis, M., Krishnan, V., & Mitragotri, S. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10122 · Cited by 162
Recent Advances in Macrophage-Mediated Drug Delivery Systems
Liang, T., Zhang, R., Liu, X., Ding, Q., Wu, S., Li, C., Lin, Y., Ye, Y., Zhong, Z., & Zhou, M. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s298159 · Cited by 126
“However, existing polymer materials are not completely inert, which prevents their clinical application as drug carriers.(36) Therefore, macrophages have been used to replace polymer materials due to their potentially higher biocompatibility and ability to be fully metabolized into safe, non-toxic products.”
Background
Metadata
- Authors
- Su, H., Wang, Y., Gu, Y., Bowman, L., Zhao, J., & Ding, M.
- Venue
- Journal of Applied Toxicology
- Publisher
- Wiley
- Published
- 2017-06-06
- Volume
- 38
- Issue
- 1
- Pages
- 3-24
- ISSN
- 0260-437X (ISSN-L)
- 1099-1263
- OpenAlex
- W2621527800
- Cited by
- 178
- References
- 228
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.